Identification of Elite Neutralizers With Broad and Potent Neutralizing Activity Against Human Cytomegalovirus (HCMV) in a Population of HCMV-Seropositive Blood Donors-Reference-Cited by-同舟云学术

Identification of Elite Neutralizers With Broad and Potent Neutralizing Activity Against Human Cytomegalovirus (HCMV) in a Population of HCMV-Seropositive Blood Donors

Published:2018-04-19 Issue:6 Volume:218 Page:876-885
ISSN:0022-1899
Container-title:The Journal of Infectious Diseases
language:en
Short-container-title:

Author:

Falk Jessica Julia¹,Winkelmann Martina²,Stöhr Dagmar¹,Alt Mira³,Schrezenmeier Hubert²⁴,Krawczyk Adalbert³,Lotfi Ramin²⁴,Sinzger Christian¹^ORCID

Affiliation:

1. Institute for Virology, Ulm University Medical Center, Ulm, Germany

2. Institute for Clinical Transfusion Medicine and Immunogenetics Ulm, German Red Cross Blood-Transfusion Service Baden-Württemberg–Hessen and University Hospital, Ulm, Germany

3. Institute for Virology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany

4. Institute for Transfusion Medicine, Ulm University, Ulm, Germany

Funder

Else Kröner-Fresenius-Foundation

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Link

http://academic.oup.com/jid/article-pdf/218/6/876/25469576/jiy229.pdf

Reference50 articles.

1. Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomised controlled trials;Hodson;Lancet,2005